CI Investments Inc’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.86M Buy
16,614
+1,785
+12% +$587K 0.02% 306
2025
Q4
$5.2M Sell
14,829
-1,430
-9% -$483K 0.02% 295
2025
Q3
$5.25M Sell
16,259
-10,128
-38% -$3.15M 0.02% 293
2025
Q2
$10.3M Buy
26,387
+8,187
+45% +$3.29M 0.04% 220
2025
Q1
$7.92M Sell
18,200
-3,100
-15% -$1.24M 0.03% 245
2024
Q4
$7.86M Sell
21,300
-43,451
-67% -$18.2M 0.03% 259
2024
Q3
$33.7M Buy
64,751
+9,372
+17% +$5.01M 0.13% 135
2024
Q2
$30M Buy
55,379
+1,188
+2% +$628K 0.12% 135
2024
Q1
$28.1M Buy
54,191
+40,958
+310% +$20.4M 0.11% 142
2023
Q4
$6.24M Sell
13,233
-900
-6% -$416K 0.03% 258
2023
Q3
$6.15M Sell
14,133
-1,532
-10% -$695K 0.03% 247
2023
Q2
$6.96M Sell
15,665
-89,451
-85% -$41.3M 0.04% 243
2023
Q1
$48.3M Sell
105,116
-68,359
-39% -$32.5M 0.24% 105
2022
Q4
$89M Sell
173,475
-66,504
-28% -$33.8M 0.45% 69
2022
Q3
$109M Sell
239,979
-1,516
-0.6% -$725K 0.57% 45
2022
Q2
$117M Sell
241,495
-54,432
-18% -$26.9M 0.54% 47
2022
Q1
$145M Sell
295,927
-12,488
-4% -$5.71M 0.53% 46
2021
Q4
$142M Sell
308,415
-11,540
-4% -$4.85M 0.49% 57
2021
Q3
$119M Sell
319,955
-136,962
-30% -$52.1M 0.44% 64
2021
Q2
$174M Sell
456,917
-163,627
-26% -$62.5M 0.64% 45
2021
Q1
$223M Sell
620,544
-162,752
-21% -$52.3M 0.94% 27
2020
Q4
$252M Sell
783,296
-207,282
-21% -$63.6M 1.11% 18
2020
Q3
$266M Sell
990,578
-138,056
-12% -$37.1M 1.32% 12
2020
Q2
$297M Sell
1,128,634
-190,236
-14% -$50.8M 1.58% 11
2020
Q1
$299M Sell
1,318,870
-82,949
-6% -$22.6M 1.82% 8
2019
Q4
$423M Sell
1,401,819
-392,669
-22% -$108M 2.15% 3
2019
Q3
$431M Buy
1,794,488
+369,415
+26% +$101M 2.23% 2
2019
Q2
$403M Buy
1,425,073
+247,896
+21% +$67.7M 2.24% 3
2019
Q1
$338M Sell
1,177,177
-64,096
-5% -$18.5M 1.89% 4
2018
Q4
$326M Buy
1,241,273
+979,273
+374% +$269M 2.1% 4
2018
Q3
$71.8M Buy
262,000
+77,300
+42% +$20.1M 0.54% 62
2018
Q2
$44M Sell
184,700
-7,800
-4% -$1.81M 0.35% 86
2018
Q1
$42.3M Buy
+192,500
New +$45.2M 0.49% 65
2017
Q4
Sell
-402,100
Closed -$76.4M 210
2017
Q3
$76.4M Sell
402,100
-225,500
-36% -$42.9M 0.75% 44
2017
Q2
$118M Sell
627,600
-187,800
-23% -$33.7M 1.28% 21
2017
Q1
$135M Sell
815,400
-1,600
-0.2% -$255K 1.53% 18
2016
Q4
$117M Buy
817,000
+121,850
+18% +$16.3M 1.29% 21
2016
Q3
$87.1M Buy
695,150
+548,650
+375% +$70.8M 0.95% 35
2016
Q2
$19.2M Buy
+146,500
New +$20M 0.22% 97

Other funds holding ELV

CI Investments Inc's ELV Position: Q1 2026 in Review

CI Investments Inc increased its Elevance Health (ELV) stake by 12% in Q1 2026, buying an estimated $587K and bringing the position to 16,614 shares worth $4.86M. The position accounts for 0.02% of the portfolio, ranked #306.

CI Investments Inc first reported a position in ELV in Q2 2016 and has held it in 39 quarters since. The position peaked at $431M in Q3 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • CI Investments Inc held 16,614 shares of Elevance Health worth $4.86M as of Q1 2026.
  • CI Investments Inc bought 1,785 Elevance Health shares in Q1 2026, an estimated $587K.
  • Elevance Health made up 0.02% of CI Investments Inc's portfolio in Q1 2026, its #306 holding.
  • CI Investments Inc first reported a position in Elevance Health in Q2 2016 and has held it in 39 quarters since.
  • CI Investments Inc's Elevance Health position peaked at $431M in Q3 2019.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on CI Investments Inc's 13F filing for Q1 2026, filed 13 May 2026.